Tag: IgAN

Novartis IgAN information in New England Magazine of Medication display Fabhalta® slowed kidney serve as decline via 49.3%
Company Announcement

Novartis IgAN information in New England Magazine of Medication display Fabhalta® slowed kidney serve as decline via 49.3%

Fabhalta reduced probability of development to kidney failure via 43% in APPLAUSE-IgAN…

spsingh
spsingh